Selma Özlem Çelikdelen

Dr. Selma Özlem Çelikdelen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2025 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
Betül Çiğdem YortanlıBetül Çiğdem Yortanlı
Betül Çiğdem Yortanlı
ÜCÜmmügülsüm Can
Ümmügülsüm Can
Mehmet YortanlıMehmet Yortanlı
Mehmet Yortanlı
KKKorhan Kollu
Korhan Kollu
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
Graves’ disease (GD) is an autoimmune thyroid disorder characterized by excessive thyroid hormone production driven by thyroid-stimulating hormone (TSH) receptor antibodies (TRAb). This study aimed to investigate the relationship between serum spexin (SPX) levels, TRAb levels, thyroid ultrasound findings, and metabolic parameters in GD patients while evaluating SPX as a potential biomarker for autoimmune inflammation. A prospective, single-center study included 45 GD patients and 45 healthy controls. Serum TSH, free T3, free T4, anti-thyroglobulin, antithyroid peroxidase, TRAb, and SPX levels were measured. Thyroid ultrasonography classified patients into mild, moderate, and high heterogeneity groups. SPX levels were significantly higher in GD patients compared to controls (p < 0.001) and showed a strong positive correlation with TRAb levels (r = 0.579, p < 0.001) and thyroid heterogeneity (p < 0.001). Newly diagnosed patients (<6 months) exhibited the highest SPX levels, which decreased with prolonged disease duration. Receiver operating characteristic analysis identified a cutoff value of 105 pg/mL for SPX, yielding 60% sensitivity and 91.1% specificity (area under the curve: 0.765, p < 0.001). SPX levels were also inversely correlated with disease duration and positively associated with inflammatory markers, suggesting its utility in monitoring disease activity and progression. These findings highlight SPX as a novel biomarker for assessing disease severity and autoimmune inflammation in GD. Incorporating SPX measurements into clinical practice may aid in early diagnosis, disease stratification, and therapeutic monitoring, ultimately improving personalized care for GD patients.

23 February 2026 in Eurasian Journal of Emergency Medicine
Verified
Journal Article
Open access
PDF file
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
MKMuhammet Cemal Kızılarslanoğlu
Muhammet Cemal Kızılarslanoğlu
Comparative Evaluation of Inflammatory, Nutritional and Composite Indices in Acute Pancreatitis - Eurasian Journal of Emergency Medicine

3 April 2025 in European Journal of Rheumatology
Verified
Journal Article
Open access
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
RBReyhan Bilici
Reyhan Bilici
Catastrophic antiphospholipid syndrome,multi-organ failure,aggressive treatment,case report,mortality

25 October 2024 in Medicine
Verified
Journal Article
Open access
OAOguzhan Aksu
Oguzhan Aksu
UCUmmugulsum Can
Ummugulsum Can
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
BYBetul Cigdem Yortanli
Betul Cigdem Yortanli
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
AGAyse Gunay
Ayse Gunay
Hashimoto thyroiditis (HT) is chronic lymphocytic thyroiditis. Cytokines and chemokines such as tumor necrosis factor-alpha, interferon-gamma, and interleukin-1 beta originating from immune cells are involved in the etiopathogenesis of HT. Spexin (SPX) is a recently identified novel peptide hormone consisting of 14 amino acids and has been demonstrated in follicle epithelial cells in thyroid tissue. SPX has been shown to affect the inflammatory response and play a role in its regulation in various diseases. There is a need for markers for diagnosis and treatment of HT patients with negative antibody levels. We found that there is no study in the literature that investigates the HT and the role of spexin in this inflammatory process. Forty-five patients aged 18 to 70 years with HT or newly diagnosed HT and 42 healthy subjects as the control group were included in the study. Patients in the HT group were divided into 3 categories according to ultrasound findings. Mild heterogeneity was called grade 1 (G1), moderate heterogeneity was called grade 2 (G2), and high heterogeneity was called grade 3 (G3). Laboratory parameters and anthropometric measurements of all patients participating in the study were performed, and SPX was measured by the ELISA method. There was no significant difference between the HT and control groups in terms of SPX levels (P = .27). In HT subgroup analysis, SPX levels were found to be borderline statistically significantly higher in the G2 group, where antibody levels were higher compared to other groups (P = .061). In our study, we evaluated SPX levels in HT patients, which has never been done before in the literature. We found high SPX levels in HT patients with high antibody levels. Multicenter studies with high case series, especially at the tissue level, are needed to fully explain the role of SPX in HT immunoetiopathogenesis and to understand immune-checkpoint pathways more clearly.

10 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZKZeynep Keskin
Zeynep Keskin
OİOnur İnan
Onur İnan
OOOmer Ozberk
Omer Ozberk
RBReyhan Bilici
Reyhan Bilici
SSSema Servi
Sema Servi
MYMehmet Yıldırım
Mehmet Yıldırım
Background and Objective: Axial spondyloarthritis (axSpA) is a group of chronic inflammatory diseases that primarily affect the sacroiliac joints. Early diagnosis is crucial for preventing irreversible structural damage. Magnetic Resonance Imaging (MRI) is the gold standard for detecting early inflammatory changes such as sacroiliitis. However, conventional MRI interpretation is inherently subjective and susceptible to both intra- and inter-observer variability. Therefore, artificial intelligence (AI)-driven diagnostic solutions are increasingly being explored. Among them, the Gated Attention Multiple Instance Learning (MIL) framework holds strong potential in modeling heterogeneous inflammatory distributions, thanks to its slice-level attention mechanism. This study aims to evaluate the diagnostic performance of a deep learning model based on Gated Attention MIL for automated sacroiliitis detection. Furthermore, its results are compared with a baseline deep learning architecture (standard ResNet-18), and its consistency with radiologist annotations is analyzed. Materials and Methods: The dataset included 554 subjects, comprising 276 patients diagnosed with axSpA and 278 healthy controls. All MRI data were derived from axial T2-weighted fat-suppressed (T2_TSE_TRA_FS) sequences. Patient-wise data splitting was employed to construct training, validation, and independent test sets. The proposed model architecture integrates ResNet-18-based feature extraction, a gated attention mechanism for instance-level weighting, and bag-level classification. Additionally, Test-Time Augmentation (TTA) was implemented to enhance robustness during inference. Results: On the independent test set, the model achieved an accuracy of 85.88%, sensitivity of 92.86%, specificity of 79.07%, and an F1-score of 86.67%. Attention heatmaps generated by the MIL module showed strong spatial overlap with bone marrow edema regions annotated by expert radiologists. Implementation of TTA led to an approximate 10% improvement in overall classification accuracy. Conclusions: The Gated Attention MIL framework demonstrated high diagnostic performance for sacroiliitis detection, indicating its value as a reliable decision support tool for early axSpA diagnosis. Validation on larger, multi-center datasets is warranted to ensure generalizability and to support clinical integration in routine radiology workflows.

18 June 2025 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
RBReyhan Bilici
Reyhan Bilici
GAGizem Tuğçe Alp
Gizem Tuğçe Alp
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
MÖMehmet Akif Öztürk
Mehmet Akif Öztürk
MKMurat Kekilli
Murat Kekilli